marinfosec.com

What It Is

Marin Cyber Risk Management serves regulated industries such as biotech, pharmaceuticals, and fintech, providing cyber risk governance and Fractional/vCISO services. Its core positioning is to help mid-sized companies without a full-time CISO or security leader build auditable cybersecurity programs that can be explained to boards and investors, while aligning with regulatory requirements such as SOX, HIPAA, FDA, and NIS2.

Core Capabilities

Based on the available text, it is closer to high-level security governance consulting than a traditional security product. Its coverage includes SOX ITGC audit readiness, regulatory examination support, third-party risk management (TPRM) buildout or remediation, incident response and business continuity capability development, and policy framework development. Delivery is primarily service-based: Fractional/vCISO work is offered on a monthly retainer model, while fixed-scope engagements focus on defined outcomes such as compliance readiness assessments, TPRM, policy frameworks, and audit preparation. It also mentions using scripts, automation, and AI-assisted tools to improve delivery efficiency, but does not disclose specific platforms or integration lists.

Pricing and Compliance

For pricing, the website only states that vCISO services are offered as a monthly retainer, with additional fixed-scope engagements available. It does not publish prices, service tiers, or delivery timelines. On the compliance side, its services emphasize alignment with SOX, HIPAA, FDA, and NIS2, and helping companies pass SOX ITGC and regulatory audits. However, it does not state whether the company itself holds ISO, SOC 2, or other third-party certifications.

Pros and Cons

Its strengths are a clear industry focus and a good fit for mid-sized companies under strong regulatory pressure but without a complete security management layer. The service scope covers board communication, audits, TPRM, and incident readiness, which are closely aligned with real management-level needs. The drawbacks are limited public information, with a lack of customer cases, team size details, regional coverage, tool integrations, and pricing transparency. It also does not show capabilities around continuous monitoring, alert operations, or a productized dashboard.

Who It’s For and China Access

It is suitable for overseas mid-sized life sciences and fintech companies preparing for SOX audits, FDA cybersecurity requirements, investor due diligence, or third-party risk remediation. For Chinese companies, information on website access, payment, local contracts, Chinese-language delivery, and adaptation to Chinese regulations is not disclosed, so china_access can only be considered unknown. If a company is mainly focused on China’s MLPS, critical information infrastructure requirements, data export compliance, or local audits, it may be better to first evaluate domestic security consultancies, GRC/TPRM platforms, or the local cybersecurity teams of major consulting firms.